V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10480411 | 10063532 | 1.51 | 54.5 | 03 | 2019-08-30 | 2019-09-05 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101360197 |
| 10480513 | 10063533 | 1.69 | null | Adjuvant (A) | 2020-05-31 | 2020-05-31 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100270357 |
| 10480527 | 10063534 | null | 66.7 | 03 | 2020-12-08 | 2020-12-09 | RUXOLITINIB | 02 | N | DARATUMUMAB | 100957815 |
| 10480569 | 10063535 | 1.63 | 72.75 | Adjuvant (A) | 2015-06-05 | 2016-07-17 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101368467 |
| 10480584 | 10063536 | 0 | 0 | null | 2019-11-20 | 2019-11-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100826685 |
| 10480606 | 10063537 | null | 71 | 03 | 2015-10-02 | 2016-06-25 | Bendamustine+Rituximab(Sub Courses) | N | N | BENDAMUSTINE + RITUXIMAB | 101300159 |
| 10480646 | 10063538 | 1.72 | 108.8 | null | 2021-10-28 | 2022-04-16 | Venetoclax | 02 | null | VENETOCLAX | 101402707 |
| 10480656 | 10063539 | 1.75 | 79 | null | 2019-03-29 | 2019-05-27 | FLUOROURACIL + IRINOTECAN | 01 | null | FLUOROURACIL + IRINOTECAN | 100881397 |
| 10480657 | 10063540 | 1.79 | 77.4 | null | 2018-09-09 | 2018-09-10 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101607099 |
| 10480685 | 10063541 | 0 | 93.3 | null | 2018-03-29 | 2018-03-29 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101028572 |
| 10480759 | 10063543 | 1.57 | 81 | null | 2018-04-02 | 2018-04-09 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101519673 |
| 10480802 | 10063544 | 1.81 | 70 | Unknown (U) | 2020-07-15 | 2020-11-01 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100392430 |
| 10480829 | 10063545 | 1.54 | 87.2 | Adjuvant (A) | 2021-03-14 | 2021-04-07 | Avelumab | 02 | N | RUXOLITINIB | 100092207 |
| 10480863 | 10063546 | 1.66 | 70 | null | 2016-07-05 | 2016-07-07 | DARATUMUMAB | 02 | null | CAPECITABINE + OXALIPLATIN | 100610907 |
| 10480933 | 10063547 | 1.85 | 92.4 | 03 | 2017-06-01 | 2019-04-10 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101083981 |
| 10480975 | 10063548 | 1.7 | 107.3 | null | 2018-11-25 | 2019-06-18 | Avelumab | 02 | null | AVELUMAB | 101066240 |
| 10480988 | 10063549 | 1.75 | 64.1 | null | 2021-09-20 | 2021-10-11 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100625190 |
| 10480995 | 10063550 | 1.72 | 56.2 | null | 2021-02-14 | 2021-03-14 | CEMIPLIMAB | 99 | null | CEMIPLIMAB | 101534738 |
| 10481070 | 10063551 | 1.59 | 99.1 | 03 | 2018-06-30 | 2019-01-29 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101718746 |
| 10481116 | 10063552 | 1.76 | 67.4 | null | null | 2019-08-06 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100190087 |
| 10481125 | 10063553 | 1.65 | 78.5 | null | 2021-05-14 | 2021-05-29 | Avelumab | 02 | null | AVELUMAB | 100572122 |
| 10481148 | 10063554 | 1.58 | 0 | Neo-adjuvant (N) | 2021-05-16 | 2021-05-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101486603 |
| 10481182 | 10063555 | 1.59 | 56.4 | null | 2021-11-27 | 2021-11-27 | Avelumab | 02 | null | AVELUMAB | 100901893 |
| 10481225 | 10063556 | 1.77 | 55 | 03 | null | 2021-07-19 | Avelumab | 02 | N | VENETOCLAX | 101223151 |
| 10481308 | 10063557 | 1.79 | 79.5 | Palliative (P) | 2019-10-31 | 2019-11-15 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101289950 |
| 10481333 | 10063558 | 1.65 | 58 | null | 2020-12-22 | 2020-12-23 | Trastuzumab | 02 | null | TRASTUZUMAB | 100726379 |
| 10481547 | 10063560 | 1.79 | 51 | null | 2018-06-26 | 2018-11-15 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100868295 |
| 10481594 | 10063561 | 1.65 | 71.8 | null | 2022-02-08 | 2022-03-13 | Avelumab | 02 | null | DARATUMUMAB | 100636612 |
| 10481676 | 10063562 | 1.69 | 121.9 | null | 2019-01-05 | 2019-09-13 | Venetoclax | null | null | VENETOCLAX | 101247159 |
| 10481719 | 10063563 | 1.73 | 64.85 | null | 2016-02-06 | 2016-02-06 | Venetoclax | 02 | null | VENETOCLAX | 100027387 |
| 10481992 | 10063564 | 1.74 | 70 | Curative (C) | 2019-05-29 | 2019-06-19 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100947385 |
| 10482062 | 10063565 | 1.86 | 52 | Palliative (P) | 2021-09-03 | 2022-03-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101177727 |
| 10001985 | 10063567 | 1.79 | 67.4 | Palliative (P) | 2017-12-10 | 2017-12-23 | Venetoclax | 02 | N | VENETOCLAX | 101801414 |
| 10003070 | 10063568 | null | 99.3 | null | 2016-10-02 | 2016-10-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100060900 |
| 10003300 | 10063569 | 1.86 | 0 | null | 2019-02-18 | 2021-03-17 | Avelumab | 02 | null | DARATUMUMAB | 101550335 |
| 10005537 | 10063570 | 1.55 | 87 | Palliative (P) | 2020-04-28 | 2020-05-16 | Venetoclax | 02 | N | VENETOCLAX | 100835477 |
| 10006298 | 10063571 | 1.62 | null | null | 2021-03-20 | 2022-03-08 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100459758 |
| 10007087 | 10063572 | 1.75 | 90.4 | Palliative (P) | 2020-01-07 | 2020-01-07 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100256925 |
| 10007213 | 10063573 | 1.69 | 97 | Palliative (P) | 2019-11-23 | 2020-01-09 | Venetoclax | 02 | N | VENETOCLAX | 101541619 |
| 10007887 | 10063574 | 1.74 | null | null | 2021-11-29 | 2021-12-26 | Oxaliplatin + Modified de Gramont | null | null | FLUOROURACIL + OXALIPLATIN | 101542227 |
| 10010251 | 10063575 | 1.56 | 66 | null | 2016-11-02 | 2016-12-15 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100003135 |
| 10010523 | 10063576 | 1.73 | 80 | Adjuvant (A) | 2021-09-09 | 2021-09-25 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101444972 |
| 10016887 | 10063577 | 1.79 | 66.4 | Adjuvant (A) | 2018-11-27 | 2018-11-27 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101202901 |
| 10017166 | 10063578 | 1.69 | 61 | null | 2018-08-25 | 2018-08-25 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100287119 |
| 10017687 | 10063579 | 1.63 | 83.8 | Palliative (P) | 2017-04-22 | 2017-04-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100544013 |
| 10018584 | 10063581 | 1.61 | 57.3 | null | 2021-09-14 | 2021-10-10 | Avelumab | 02 | null | AVELUMAB | 101088419 |
| 10021167 | 10063583 | 1.63 | 77 | Palliative (P) | 2016-10-09 | 2016-10-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101324634 |
| 10023603 | 10063584 | 1.63 | 78.8 | null | 2020-02-23 | 2020-02-24 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100822150 |
| 10024439 | 10063585 | 1.73 | 63 | null | 2022-04-13 | 2022-05-01 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101353491 |
| 10024742 | 10063586 | 1.62 | 77.6 | null | 2017-10-23 | 2017-10-24 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101230062 |